FDA approval provides targeted treatment option for patients with rare DMD mutation
02/25/2021

FDA approval provides targeted treatment option for patients with rare DMD mutation

Today, the U.S. Food and Drug Administration granted approval for Amondys 45 (casimersen) injection ...
read more